Journal Articles

Donald and Barbara Zucker School of Medicine
Academic Works

2014

Pharmacologically induced erect penile length and
stretched penile lengh are both good predictors of
post-inflatable prosthesis penile length
E. C. Osterberg
A. Maganty
R. Ramasamy
J. F. Eid
Northwell Health

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Urology Commons
Recommended Citation
Osterberg E, Maganty A, Ramasamy R, Eid J. Pharmacologically induced erect penile length and stretched penile lengh are both good
predictors of post-inflatable prosthesis penile length. . 2014 Jan 01; 26(4):Article 188 [ p.]. Available from:
https://academicworks.medicine.hofstra.edu/articles/188. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for
inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works.

NIH Public Access
Author Manuscript
Int J Impot Res. Author manuscript; available in PMC 2015 February 26.

NIH-PA Author Manuscript

Published in final edited form as:
Int J Impot Res. 2014 ; 26(4): 128–131. doi:10.1038/ijir.2013.50.

Pharmacologically induced erect penile length and stretched
penile lengh are both good predictors of post-inflatable
prosthesis penile length
EC Osterberg1, A Maganty2, R Ramasamy1, and JF Eid3
1Department

of Urology, Weill Cornell Medical College, New York-Presbyterian Hospital, New
York, NY, USA

2Weill

Cornell Medical College, New York, NY, USA

3Depeartment

of Urology, North Shore Long Island Jewish Lenox Hill Hospital, New York, NY,

USA

NIH-PA Author Manuscript

Abstract
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Inflatable penile prosthesis (IPP) remains the gold standard for the surgical treatment of refractory
erectile dysfunction; however, current literature to aid surgeons on how best to counsel patients on
their postoperative inflated penile length is lacking. The aim of this study was to identify
preoperative parameters that could better predict postoperative penile length following insertion of
an IPP. Twenty men were enrolled in a prospective study examining penile lengths before and
after IPP surgery. Patients with Peyronie’s disease were excluded from this analysis. Baseline
preoperative characteristics, including body mass index, history of hypertension, diabetes, Sexual
Health Inventory for Men scores and/or prior radical prostatectomy were recorded. All patients
underwent implantation with a three-piece inflatable Coloplast penile prosthesis. We compared
stretched penile length to pharmacologically induced erect lengths. Postoperatively, we measured
inflated penile lengths at 6 weeks and assessed patients’ perception of penile size at 12 weeks. The
median (± interquartile range) stretched penile length and pharmacologically induced erect penile
length was 15 (± 3) and 14.25 (± 2) cm, respectively (P = 0.5). Median post-prosthesis penile
length (13.5 ± 2.13 cm) was smaller than preoperative pharmacologically induced length (P =
0.02) and preoperative stretched penile length (P = 0.01). The majority of patients (70%) had a
decrease in penile length (median loss 0.5 ± 1.5 cm); however, this loss was perceptible by 43% of
men. Stretched penile length and pharmacologically induced erect penile length were equally good
predictors of postoperative inflated length (Spearman’s correlation 0.8 and 0.9, respectively).
Pharmacologically induced erect penile length and stretched penile lengths are equal predictors of
post-prosthesis penile length. The majority of men will experience some decrease in penile length
following prosthesis implantation; however <50% report a subjective loss of penile length.
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INTRODUCTION
Erectile dysfunction (ED) is a common disease that affects >500 000 men annually.1 With
the overall increasing incidence of diabetes, obesity and cardiovascular-associated
comorbidities in the United States, ED certainly will remain a prevalent disease that impacts
quality of life and could be a predictor of overall cardiovascular health.2
Current treatment(s) for ED include vacuum-erection devices, type 5 phosphodiesterase type
5 phosphodiesterase inhibitors, intraurethral prostaglandin E1 and intracavernosal injection
(ICI). Penile prosthesis implantation remains the gold standard for patients who do not
respond to or fail medical treatment for ED.
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Inflatable penile prostheses (IPP) have excellent long-term patient satisfaction rates,
generally above 90%.3 Patient satisfaction is often centered around erectile function, penile
length, cosmetic outcome and partner acceptability.4 Despite patient’s overall satisfaction,
some patients may complain of a subjective reduction in postoperative penile length,5,6
despite the fact that most men have similar penile length.7 To this end, surgeons have
attempted augmentation techniques to improve girth, reduce pubic fat pad size and increase
glans firmness; however, long-term follow-up data is lacking.8,9 Ultimately, appropriate
patient selection, proper preoperative counseling and setting realistic expectations may
improve overall patient satisfaction.
Several authors have examined the relationship between preoperative penile length via
stretch10 or ICI,11 and post-prosthesis penile length; however, to our knowledge there are no
studies comparing ICI versus stretched penile length to postoperative inflated penile length.
Aims
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In this study, we prospectively evaluated 20 men who underwent initial IPP surgery. We
hypothesized that preoperative pharmacologically induced erect penile length would be the
best predictor of postoperative inflated penile length. Our primary outcome was comparing
post-prosthesis penile length to various preoperative measurements. Our secondary outcome
was the subjective assessment of penile length loss and patient perception.

MATERIALS AND METHODS
Twenty consecutive patients underwent preoperative evaluation with informed consent of
our study protocol by a single surgeon from April to August 2012. Intake history and
physical were conducted, including the presence of diabetes, cardiovascular disease,
including hypertension, and hyperlipidemia. All patients completed a Sexual Health
Inventory for Men questionnaire.12 A prior surgical history, including a history of radical
prostatectomy, was recorded. Complete examination of penile length was performed.
Measurements included flaccid penile length—the distance from the pubic bone toward the
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tip of glans penis in centimeters—as well as the pharmacologically induced erect penile
length in centimeters. To achieve a pharamologically induced erection, 10 µg of alprostadil,
a prostaglandin E1 agonist was used. After tumescence, the erect length was measured.
Additional intracavernosal dosing of alprostadil in increments of 5 µg was used when
necessary, to facilitate an erection firm enough for sexual penetration. The maximal amount
of alprostadil used was 25 µg. Nonresponders to ICI and men using a vacuum-erectile device
preoperatively were excluded from this study. Penile duplex sonography was performed to
measure cavernous artery diameter, peak systolic velocity and cavernous artery end diastolic
velocity.
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All patients underwent a three-piece inflatable Coloplast (Minneapolis, MN, USA) penile
prosthesis using a peno-scrotal approach by a single surgeon (JFE). Preoperative antibiotic
prophylaxis was used according to the American Urologic Association best practice
guidelines.13 The No-Touch-technique was used in all cases in effort to reduce postoperative
infection rates.14,15 Intraoperative cylinder sizing was performed in a standardized manner
in all cases. First, corporal dilation is performed after corporotomy with the blunt tips of a
long curved Mayo scissors followed by a 13/14 Hegar dilator. Next, a Dilamezinsert is used
to measure the distal and proximal corporal lengths to the edge of the corporotomy as a
fixed point of reference. Caution is taken not to overstretch the penis or alter our traction
stitch in the corporotomy, which may lead to oversizing. Patients are discharged with the
implant partially inflated with the penis placed in an upright position against the abdomen
via a jockstrap. Around 3–4 weeks postoperatively, patients will begin cycling the device.
At 6 weeks postoperatively, patients’ post-prosthesis inflated penile length was recorded,
measuring from pubic bone to the tip of the glans penis. At 12 weeks postoperatively,
patients returned to the office to complete a questionnaire assessing their satisfaction (see
Appendix 1).
Main outcome measures
Comparisons were made between preoperative and postoperative penile measurements using
a χ2-test, paired t-test, Wilcoxon rank-sum test and Spearman’s tests as indicated. Statistical
significance was defined as a P≤0.05. All statistical analysis was done using SPSS v20.0
(IBM Corporation, Armonk, NY, USA).
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RESULTS
The demographic and baseline characteristics of the 20 men in this study are reported in
Table 1.
The median (interquartile range) preoperative stretched penile length was 15 (± 3) cm and
was similar to pharmacologically induced erect penile length (14.25 (± 2) cm; P = 0.5).
After IPP implantation, the median (interquartile range) inflated penile length was 13.5 (±
2.13) cm at 6 weeks. The median (interquartile range) cylinder size placed intraoperatively
was 22 cm (± 4 cm) Fourteen patients (70%) had a smaller (0.5 ± 1.5 cm) postoperative
penile length when compared with their pharmacological-induced penile length (P = 0.02).
There was also a decrease in penile length after implantation compared with preoperative

Int J Impot Res. Author manuscript; available in PMC 2015 February 26.

Osterberg et al.

Page 4

stretched penile length (15 ± 3 vs 13.5 ± 2.13 cm; P = 0.01). At 6 weeks, no patient had
developed a supersonic transportation-like deformity.
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Of all the preoperative factors examined and/or measured, preoperative stretched penile
length and pharmacologically induced erect penile length were equal predictors of
postoperative penile length by linear regression and Spearman correlation. (Table 2) The
difference between these correlation coefficients was not significant (0.8 vs 0.9, P>0.05).
Of the 20 patients, 12 men had a measured difference of 1 cm or more between their
preoperative pharmacologically induced erect penile length and postoperative inflated penile
length. Patients with a prior history of radical prostatectomy were more likely to have a
length discrepancy of >1 cm (42% vs 0%, P = 0.04; Table 3).
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At 12 weeks postoperatively, 86% of men subjectively perceived a change in penile length
following IPP implantation, of which 43% perceived a smaller postoperative penile size and
43% perceived a larger penile length. Of those men who reported a subjective change in
size, 57% had an objective decrease in their postoperative penile length ≥1 cm when
compared with their pharmacological induced penile length, suggestive that 14% of men did
not perceive a preoperative to postoperative size discrepancy. Of this select cohort reporting
a subjective and objective decrease in size, 66% had undergone a prior radical
prostatectomy.

DISCUSSION
Men undergoing penile prosthesis implantation should be counseled on their expected
postoperative penile functionality and size; however, only a few studies exist guiding
physicians with evidence on which preoperative factors best predict postoperative penile
size.
In this study, our primary aim was to evaluate preoperative and postoperative penile lengths
and compare which measurements were predictive of penile length at 6 weeks
postoperatively. Our secondary aim was to describe the relationship between objective
versus subjective loss in penile length.
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Here we present a prospective cohort of 20 patients who underwent first-time Coloplast
Titan three-piece inflatable penile prosthesis (IPP) by a single surgeon (JFE) from April
2012 to August 2012. We found that both stretched penile length and pharmacologically
induced erect penile length are excellent predictors of postoperative inflated penile length (R
= 0.8 and 0.9, respectively). Surgeons may find performing ICI advantageous over stretched
penile length because it allows for examination of penile anatomic abnormalities (that is,
extent of curvature and/or hour-glass deformity), which may be useful before prosthesis
insertion. The majority of men will experience an objective decrease in penile length after
prosthesis insertion (median loss 0.5 ± 1.5 cm); however, this discrepancy was perceptible
only in 43% of men.
To our knowledge, this study is the first to compare the performance of both stretched penile
length and pharmacologically induced erect penile length in the same cohort to inflated

Int J Impot Res. Author manuscript; available in PMC 2015 February 26.

Osterberg et al.

Page 5

NIH-PA Author Manuscript

penile length measurements. A prior study by Wessells et al.16 prospectively compared
flaccid, stretched and pharmacological-induced penile lengths in 80 men. Their data
similarly confirm a close correlation between stretched and pharmacologically induced
penile length (correlation coefficient = 0.8 vs 0.83 in our data set). This cohort, however, did
not undergo IPP implantation.
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Deveci et al.10 first examined stretched penile lengths versus post-prosthesis erect penile
lengths in 56 men undergoing first-time implantation secondary to a variety of etiologies.
Surprisingly, there was no statistical difference noted between pre- and postoperative penile
lengths objectively; however, 72% of patients reported subjective length decreases, which
corresponded to lower satisfaction domain scores. This is contrary to our results whereby
there was a statistically significant difference in postoperative penile lengths versus
preoperative stretched penile lengths and pharmacologically induced erect length. Our
findings are consistent with other literature denoting a mean penile length decrease of 0.8
cm following prosthesis implantation.11 The mechanism of penile shortening following IPP
surgery is not completely understood; however, it is likely multifactorial: improper sizing
during surgery, improper pre/postoperative measurements and lack of engorgement of the
glans and/or fibrosis. To address the lack of engorgement of the glans, some authors
advocate concomitant type 5 phosphodiesterase inhibitor use17 or intraurethral
aloprostadil.18 Other authors release the penile suspensory ligament at the time of IPP
insertion19 or removal of any penoscrotal webbing;9 however, these studies were not
designed to compare preoperative versus postoperative penile lengths. Most recently, Henry
et al.20 described a new penile implant length measurement technique whereby a greater
number of men received a larger implant size without any reported distal erosions. Lastly,
girth and length expanding cylinders have been used to counteract the loss in penile length
following prosthesis;21 however, these devices have been fraught with mechanical failures
and S-shaped deformities.22,23
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Interestingly, our cohort reported less subjective loss compared with the study by Deveci et
al.10 (43% vs 73%), despite cohorts having roughly equal number of men (25% vs 28.5%)
who had undergone prior radical prostatectomy. One explanation for why subjective
assessment of penile length does not fully reflect objective length discrepancy is that with
sexual activity some glans engorgement may occur that would not be apparent during officebased examination.
To examine the relationship between pharmacologically induced erect length and inflated
penile length, Wang et al.11 in 2009 prospectively enrolled 11 patients with ED secondary to
neurogenic etiologies. Preoperative ICI with 0.25 ml of Trimix was compared with
postoperative penile prosthesis lengths at 6 weeks, 6 months and 1 year. The authors report a
statistically significant decrease in postoperative length of 0.83 cm at 6 weeks There was no
statistical difference in inflated penile lengths at 6 months or 12 months when compared
with the initial postoperative measurement at 6 weeks. Although all patients in their cohort
had a decrease of erect penile length (range 0.2–3.0 cm), only 45% reported a subjective
decrease in post prosthesis. Although our cohort demonstrates similar objective
measurements and subjective perceptibility data, we report three patients having an increase
in postoperative penile length.
Int J Impot Res. Author manuscript; available in PMC 2015 February 26.
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Current literature demonstrates that penile length is reduced after prostatectomy even after
penile prosthesis implantation.24,25 In fact, several studies report that a prior radical
prostatectomy was the only demographic factor that statistically differed for those patients
complaining of length loss,10 and men with a history of radical prostatectomy have lower
overall erectile satisfaction postoperatively.5 The rationale for this phenomenon is likely due
to neuropraxia secondary to nerve damage and/or decreased arterial inflow from ligation of
the accessory internal pudendal arteries leading to ischemic apoptosis.26,27 We found that a
prior history of a radical prostatectomy was the only factor that significantly impacted a
preoperative to postoperative length discrepancy >1 cm (P = 0.04). However, we did find
that the majority of men who denoted subjective loss in penile length had undergone prior
radical prostatectomy (66%).
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This analysis is limited by a small sample size of 20 men who were operated on by a single
surgeon at a single center with a single model of prosthesis. Patients with Peyronie’s disease
were excluded from this cohort representing inherent selection bias. One individual that was
blinded to our study protocol measured all preoperative and postoperative penile lengths
without secondary confirmation. Patients were followed for a maximum of 12 weeks
postoperatively; however, current literature shows no statistical difference in inflated penile
lengths after 6 weeks.10,11 Although the Sexual Health Inventory for Men questionnaire was
administered to all patients in the preoperative setting, a non-standardized questionnaire was
used to assess patients’ postoperative satisfaction.

CONCLUSION
Preoperative pharmacologically induced erect penile length and stretched penile lengths are
equal predictors of post-prosthesis inflated penile length. ICI may be advantageous for
preoperative assessment of penile anatomy; however, peak systolic velocity and end
diastolic velocity were not predictive of postoperative inflated length. Even though the
majority of patients will experience some decrease in penile length following prosthesis
implantation, <50% of men perceive such discrepancy. Setting realistic expectations with
informed decision-making and proper preoperative counseling will lead to improved
outcomes and patient satisfaction.

NIH-PA Author Manuscript

REFERENCES
1. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of
erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male
aging study. J Urol. 2000; 163:460–463. [PubMed: 10647654]
2. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile
dysfunction and subsequent cardiovascular disease. JAMA. 2005; 294:2996–3002. [PubMed:
16414947]
3. Furlow WL, Goldwasser B, Gundian JC. Implantation of model AMS 700 penile prosthesis: longterm results. J Urol. 1988; 139:741–742. [PubMed: 3352035]
4. Mulhall JP, Ahmed A, Branch J, Parker M. Serial assessment of efficacy and satisfaction profiles
following penile prosthesis surgery. J Urol. 2003; 169:1429–1433. [PubMed: 12629377]
5. Akin-Olugbade O, Parker M, Guhring P, Mulhall J. Determinants of patient satisfaction following
penile prosthesis surgery. J Sex Med. 2006; 3:743–748. [PubMed: 16839332]

Int J Impot Res. Author manuscript; available in PMC 2015 February 26.

Osterberg et al.

Page 7

NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript

6. Montague DK. Penile prosthesis implantation: size matters. Eur Urol. 2007; 51:887–888. [PubMed:
17081674]
7. Mondaini N, Ponchietti R, Gontero P, Muir GH, Natali A, Caldarera E, et al. Penile length is normal
in most men seeking penile lengthening procedures. Int J Impot Res. 2002; 14:283–286. [PubMed:
12152118]
8. Shaeer O. Supersizing the penis following penile prosthesis implantation. J Sex Med. 2010; 7:2608–
2616. [PubMed: 20233283]
9. Miranda-Sousa A, Keating M, Moreira S, Baker M, Carrion R. Concomitant ventral phalloplasty
during penile implant surgery: a novel procedure that optimizes patient satisfaction and their
perception of phallic length after penile implant surgery. J Sex Med. 2007; 4:1494–1499. [PubMed:
17727355]
10. Deveci S, Martin D, Parker M, Mulhall JP. Penile length alterations following penile prosthesis
surgery. Eur Urol. 2007; 51:1128–1131. [PubMed: 17084508]
11. Wang R, Howard GE, Hoang A, Yuan JH, Lin HC, Dai YT. Prospective and long-term evaluation
of erect penile length obtained with inflatable penile prosthesis to that induced by intracavernosal
injection. Asian J Androl. 2009; 11:411–415. [PubMed: 19525974]
12. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an
abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic
tool for erectile dysfunction. Int J Impot Res. 1999; 11:319–326. [PubMed: 10637462]
13. Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ, et al. Best
practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol. 2008; 179:1379–
1390. [PubMed: 18280509]
14. Eid JF. No-touch technique. J Sex Med. 2011; 8:5–8. [PubMed: 21199375]
15. Eid JF, Wilson SK, Cleves M, Salem EA. Coated implants and ‘no touch’ surgical technique
decreases risk of infection in inflatable penile prosthesis implantation to 0.46%. Urology. 2012;
79:1310–1316. [PubMed: 22521187]
16. Wessells H, Lue TF, McAninch JW. Penile length in the flaccid and erect states: guidelines for
penile augmentation. J Urol. 1996; 156:995–997. [PubMed: 8709382]
17. Mulhall JP, Jahoda A, Aviv N, Valenzuela R, Parker M. The impact of sildenafil citrate on sexual
satisfaction profiles in men with a penile prosthesis in situ. BJU Int. 2004; 93:97–99. [PubMed:
14678377]
18. Benevides MD, Carson CC. Intraurethral application of alprostadil in patients with failed inflatable
penile prosthesis. J Urol. 2000; 163:785–787. [PubMed: 10687977]
19. Borges F, Hakim L, Kline C. Surgical technique to maintain penile length after insertion of an
inflatable penile prosthesis via infrapubic approach. J Sex Med. 2006; 3:550–553. [PubMed:
16681481]
20. Henry G, Houghton L, Culkin D, Otheguy J, Shabsigh R, Ohl DA. Comparison of a new length
measurement technique for inflatable penile prosthesis implantation to standard techniques:
outcomes and patient satisfaction. J Sex Med. 2011; 8:2640–2646. [PubMed: 21679300]
21. Montague DK, Angermeier KW. Increasing size with penile implants. Curr Urol Rep. 2008;
9:483–486. [PubMed: 18947513]
22. Daitch JA, Angermeier KW, Lakin MM, Ingleright BJ, Montague DK. Long-term mechanical
reliability of AMS 700 series inflatable penile prostheses: comparison of CX/CXM and Ultrex
cylinders. J Urol. 1997; 158:1400–1402. [PubMed: 9302130]
23. Wilson SK, Cleves MA, Delk JR 2nd. Ultrex cylinders: problems with uncontrolled lengthening
(the S-shaped deformity). J Urol. 1996; 155:135–137. [PubMed: 7490811]
24. Savoie M, Kim SS, Soloway MS. A prospective study measuring penile length in men treated with
radical prostatectomy for prostate cancer. J Urol. 2003; 169:1462–1464. [PubMed: 12629384]
25. Munding MD, Wessells HB, Dalkin BL. Pilot study of changes in stretched penile length 3 months
after radical retropubic prostatectomy. Urology. 2001; 58:567–569. [PubMed: 11597540]
26. Gontero P, Galzerano M, Bartoletti R, Magnani C, Tizzani A, Frea B, et al. New insights into the
pathogenesis of penile shortening after radical prostatectomy and the role of postoperative sexual
function. J Urol. 2007; 178:602–607. [PubMed: 17570431]

Int J Impot Res. Author manuscript; available in PMC 2015 February 26.

Osterberg et al.

Page 8

27. Briganti A, Fabbri F, Salonia A, Gallina A, Chun FK, Dehò F, et al. Preserved post-operative
penile size correlates well with maintained erectile function after bilateral nerve-sparing radical
retropubic prostatectomy. Eur Urol. 2007; 52:702–707. [PubMed: 17418936]

NIH-PA Author Manuscript

APPENDIX 1
Questionnaire completed by patients at 12 weeks post operatively.
1.

When your penis is flaccid (soft), do you feel like it is bigger, smaller, or the same
as compared with that before your operation (circle one)?

2.

When your penis is erect (hard) after inflation of your prosthesis, do you feel like it
is bigger, smaller, or the same as compared with that before your operation (circle
one)?
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Table 1
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Baseline demographic characteristics
N = 20
Median age (IQR)

61.5 (± 8)

HTN

9 (45%)

Diabetes

8 (40%)

Hyperlipidemia

10 (50%)

Prior radical prostatectomy

5 (25%)

Median preoperative SHIM scores (IQR)

4 (± 6.5)

Median flaccid penile length cm (IQR)
Median stretched penile length cm (IQR)
Median erect penile length after ICI, cm (IQR)
Median cylinder size cm (IQR)
Median EDV ml

s−1

Median PSV ml

s−1

10.25 (± 4)
15 (± 3)
14.25 (± 2)
22 (± 4)

(IQR)

6.7 (± 4.7)

(IQR)

36.3 (± 21)
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Abbreviations: EDV, end diastolic velocity; HTN, hypertension; ICI, intracavernosal injection; IQR, interquartile range; PSV, peak systolic
velocity; SHIM, Sexual Health Inventory for Men.
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Table 2
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Predictors of post-operative penile length
Predictors of postoperative inflated penile length

Linear regression

P-value

Spearman correlation coefficient

P-value

Stretched penile length

0.71

<0.001

0.8

<0.001

Pharmacologically induced erect penile length

0.83

<0.001

0.9

<0.001

Median PSV

−0.04

0.66

−0.07

0.76

Median EDV

−0.05

0.97

0.08

0.73

Abbreviations: EDV, end diastolic velocity; PSV, peak systolic velocity.
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Table 3
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Preoperative predictors of changes in preoperative to postoperative penile lengths

Median age

≥1 cm
Discrepancy
(n = 12)

<1 cm
Discrepancy
(n = 8)

P-value

60.5 ± 5.75

65.5 ± 12.75

0.2

HTN (%)

42%

50%

0.71

Diabetes (%)

50%

25%

0.26

Hyperlipidemia (%)

67%

25%

0.07

42%

0%

0.04

1.5 ± 5.5

5 ± 3.5

0.28

Prior radical prostatectomy (%)
Median Preoperative SHIM scores

Abbreviations: HTN, hypertension; SHIM, Sexual Health Inventory for Men.
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